Photodynamic Therapy

Photodynamic Therapy (PDT) may be used to treat the early stages of esophageal cancer. Chemicals that are sensitive to certain wavelengths of light are injected into the bloodstream and are taken up by the body’s cells. Abnormal cells take up more then normal cells. After a period of sensitization, a light source is focused upon the area containing the abnormal cells. The light causes the chemical to react inside of these cells, killing them.

There are other less common treatment approaches available, as well as many new therapies and many new clinical trials now being tested. It is not possible to list all of the ways that esophageal cancer may be treated. Esophageal cancer patients should have thorough discussions of treatment possibilities with their physicians to learn their options for treatment, given their stage of esophageal cancer and whether or not metastatic tumors are present.

Source: The Web site of the National Cancer Institute

Last updated: April 10, 2012 at 15:29 pm

Privacy Policy: The personal information collected from the visitors of our website, including their identity, remains confidential. We respect the law(s) on confidentiality applicable to this website (hosting country) and we will never pass on these data to any third party, unless required by law. Our website does not collect any cookies. The ECAA is registered with the Health on the Net (HON) Organization.
The Esophageal Cancer Awareness Association, Inc. (ECAA) is a New York State non profit corporation which is recognized as tax exempt under Section 501(c)(3) of Internal Revenue Code.

Disclaimer: This information contained in this site is for educational purposes only. The information here cannot and should not replace the guidance and opinions of your medial professional. The the authors, webmaster, the ECAA and other parties affiliated to the site have no responsibility for visitors' use of this site and/or any subsequent medical decisions or treatment.